உயிரி தொழில்நுட்பவியல் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ORION BIOTECHNOLOGY PROJECT AWARDED GRANT TO ADVANCE DRUG DISCOVERY Orion Biotechnology Canada Ltd.January 14, 2021 GMT Genève SWITZERLAND, Jan. 14, 2021 (GLOBE NEWSWIRE) Orion Biotechnology Holding SA., a biotechnology company focused on precision engineering small protein therapeutics, today announced that its drug discovery project was awarded funding of CHF 0.9M from Innosuisse, the Swiss Innovation Agency. The project will allow Orion, in collaboration with the University of Geneva, to further expand and optimize drug discovery capabilities using its novel platform. The proprietary platform driven by Dr. Oliver Hartley and his team at the University of Geneva delivers a novel approach to G Protein-Coupled Receptor (GPCR) targeting by precision-engineering natural peptide and protein analogs that bind to GPCR targets with both enhanced potency and tailored signaling activity. The

Oliver hartleyUniversity of genevaOrion biotechnology holding saAnatole klepatsky orion biotechnology holdingOrion biotechnology holdingSwiss innovation agencySwiss innovationOrion biotechnologyMark groperBiotechnology holdingG protein coupled receptorsWestern europeGlobe newswireஆலிவர் ஹார்ட்லிபல்கலைக்கழகம் ஆஃப் ஜிநீவஒரையந் உயிரி தொழில்நுட்பவியல் வைத்திருத்தல் ச